Skip to main content Skip to main navigation menu Skip to site footer
Journal of Commercial Biotechnology
  1. Home /
  2. Archives /
  3. Vol. 13 No. 2 (2007)

Vol. 13 No. 2 (2007)

Published: 2007-02-01

Commentary

  • In defence of science-based regulation

    Henry Miller
    • PDF

Article

  • Critical success factors for biotechnology industry in Canada

    Sandra Vanderbyl, Sherry Kobelak
    • PDF
  • New path to profits in biotech: Taking the acquisition exit

    Nils Behnke, Norbert Hültenschmidt
    • PDF
  • Is anyone listening?

    David C Ireland, Craig Cormick, Damian Hine
    • PDF
  • Decision-making associated with drug candidates in the biotechnology research and development (R&D) pipeline

    Grant H Skrepnek, Jeff J Sarnowski
    • PDF
  • ApaTech: A biomaterials success story

    Simon Cartmell
    • PDF
  • Dyslipidaemia: Focus shifts from LDL-C to HDL-C

    Duncan Emerton
    • PDF

Legal and Regulatory Updates

  • Legal and regulatory update

    Gerry Kamstra, John Wilkinson
    • PDF

Book Review

  • Innovation and Entrepreneurship in Biotechnology, an International Perspective: Concepts, Theories and Cases

    Simon Shohet
    • PDF
  • International Trade and Policies for Genetically Modified Products

    Thomas Kowalski
    • PDF

Copyright © 2021
Journal of Commercial Biotechnology
All rights reserved.
ISSN: 1462-8732 | eISSN: 1478-565X

Privacy Policy

Journal of Commercial Biotechnology

GoDaddy SiteSeal WebTrust